NCT01713738 - Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Idiopathic Thrombocytopenic Purpura (ITP)Immune Thrombocytopenic Purpura (ITP)

Interventions

DRUG

rituximab

infusion of 4 weekly doses of 375 mg/m2 rituximab

Trial Locations (9)

Weill Medical College at Cornell University, New York

Emory University School of Medicine, Atlanta

Van Eslander Cancer Center, St. John Hospital, Detroit

Southwestern Medical Center at Dallas, Dallas

Baylor College of Medicine, Houston

UCLA, Mattel Children's Hospital, Los Angeles

University of California, San Francisco, San Francisco

Stanford University School of Medicine, Palo Alto

Children's Hospital Boston, Boston